By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Green Cross 

107, Ihyeon-ro 30beon-gil
Yongin-si  Gyeonggi-do    Korea
Phone: 82-31-260-9300 Fax: 82-31-260-9413



Company News
Green Cross Receives Complete Response Letter From US FDA For IVIG-SN 11/23/2016 6:51:46 AM
US FDA Accepts Green Cross' Biologics License Application For IVIG-SN 1/26/2016 6:12:07 AM
Green Cross To Build Cell Therapy Manufacturing Facility In China 4/29/2015 7:25:15 AM
Green Cross To Form Cell Therapy Company In China 3/16/2015 10:03:51 AM
President Of Leading South Korean Biopharmaceutical Company Green Cross Joins Stemedica Cell Technologies, Inc.'s Board Of Directors 4/22/2014 2:35:58 PM
Aquavit and Green Cross Sign Strategic Collaboration MOU on IBX-001 Product Development and Commercialization in Asia 8/9/2012 9:58:55 AM
Green Cross Gains Market Approval With the World's 2nd Orphan Drug for Hunter Syndrome in South Korea 1/26/2012 9:42:03 AM
Jennerex and Green Cross Announce Publication of Positive Clinical Data of JX-594 in Combination With Sorafenib in Advanced Liver Cancer 4/21/2011 7:54:56 AM
Biocryst Pharmaceuticals (BCRX) Partner Green Cross Receives Marketing & Manufacturing Approval for Peramivir in South Korea 8/16/2010 8:00:29 AM
Biocryst Pharmaceuticals (BCRX)'s Partner Green Cross Files for Peramivir Regulatory Approval in South Korea 1/8/2010 9:07:33 AM